Utilizing Patient-Centered Approaches in Pulmonary Arterial Hypertension (PAH): The Expanding Role of Pharmacists- Pulmonary arterial hypertension (PAH) is a rare disease with significant consequences, including serious functional impairment and premature death. If left untreated, PAH is rapidly fatal. Fortunately, over the past decade, the knowledge and understanding of this disease has greatly expanded. Furthermore, the availability of effective and more convenient oral and inhaled medications has allowed clinicians to better individualize therapy to meet patient treatment goals. Though there is no cure for PAH, effective treatment can significantly slow disease progression and clinical worsening. Given the serious nature of this disease and its rapid progression, optimal treatment selection is essential.
The Role of the Pharmacist- Optimal management of patients with PAH requires early detection and diagnosis followed by an aggressive treatment plan. By increasing their competency, pharmacists can play an important role within the multidisciplinary team when encountering patients with this deadly and rapidly progressing disease. Given the complex and individualized nature of PAH therapy, pharmacists must have a full understanding of treatment algorithms, disease-specific therapies, and long-term monitoring recommendations based on evidence-based guidelines. As the armamentarium to treat PAH continues to expand, pharmacists must make efforts to stay informed of the latest findings in order to contribute to the optimal management of these patients.
Explain how treatment algorithms and prognostic factors can be used to individualize care for patients with PAH when selecting initial treatment.
Evaluate the role of the various therapeutic classes in the treatment of PAH, including balancing the benefits and risks of monotherapy versus combination therapy.
Discuss the role of pharmacists as part of the interprofessional healthcare team when managing patients with PAH.
1.5 Free CEUs for Pharmacists
Expires 1/11/17